Literature DB >> 6848509

The dual role of mevalonate in the cell cycle.

V Quesney-Huneeus, H A Galick, M D Siperstein, S K Erickson, T A Spencer, J A Nelson.   

Abstract

It is well established that either exogenous or endogenous cholesterol is required for both cell growth and proliferation. This laboratory has recently discovered that, in baby hamster kidney-21 cells, independent of its role as a cholesterol precursor, mevalonic acid plays an essential role in S phase DNA replication. It was later shown that isopentenyl adenine, a known product of mevalonate in prokaryotes and lower eukaryotes, is 100 to 200 times more effective than mevalonate in restoring DNA replication in cells in which mevalonic acid synthesis is blocked with the beta-hydroxy-beta-methylglutaryl-CoA reductase inhibitor, compactin. The present study was designed to determine the relationship in the cell cycle between the known requirement for cholesterol and the newly discovered effect of mevalonic acid and isopentenyl adenine on S phase DNA synthesis. Employing cells arrested by serum depletion, it was shown that the cholesterol requirement is limited to the early and mid-G1 phases, whereas the isopentenyl effect is required at the late G1-S interphase of the cell cycle. The evidence supporting these conclusions involves: first, in serum-arrested cells blocked early in G1 by compactin, only the combination of cholesterol added in early G1 and either mevalonate or isopentenyl adenine in late G1 permitted progression through the G1 and S phase DNA synthesis. Neither isopentenyl adenine added early in G1 nor cholesterol in late G1 was capable of restoring DNA synthesis in this system. Second, in accord with the above formulation, inhibition of cholesterol synthesis with the oxidosqualene cyclase inhibitor, dl-4,4,10 beta-trimethyl-trans-decal-3 beta-ol, affected only the early G1 phase of the cell cycle, but had no late G1 effect on DNA replication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848509

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Are there potential non-lipid-lowering uses of statins?

Authors:  D C Wheeler
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

2.  Alterations in 3-hydroxy-3-methylglutaryl-CoA reductase mRNA concentration in cultured chick aortic smooth muscle cells.

Authors:  A Carazo; M J Alejandre; M D Suarez; A Linares
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

Review 3.  Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae--a review.

Authors:  N D Lees; B Skaggs; D R Kirsch; M Bard
Journal:  Lipids       Date:  1995-03       Impact factor: 1.880

4.  The effect of probucol on the proliferation of cultured human umbilical vascular endothelial cells.

Authors:  T Tajika; Y Ono; K Ono; M Miura; Y Kyo
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

5.  A discoordinate increase in the cellular amount of 3-hydroxy-3-methylglutaryl-CoA reductase results in the loss of rate-limiting control over cholesterogenesis in a tumour cell-free system.

Authors:  N I Azrolan; P S Coleman
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

6.  Activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase does not respond to ubiquinone uptake in cultured cells.

Authors:  W A Maltese; J R Aprille; R A Green
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

7.  Stimulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mouse uterine epithelial cells by oestradiol-17 beta.

Authors:  P A Wilce; L Leijten; L Martin
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin.

Authors:  Jan Gliemroth; Henryk Zulewski; Hans Arnold; A Jorge A Terzis
Journal:  Neurosurg Rev       Date:  2003-05       Impact factor: 3.042

9.  The effect of mevalonic acid deprivation on enzymes of DNA replication in cells emerging from quiescence.

Authors:  J R Silber; H Galick; J M Wu; M D Siperstein
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  The squalene-2,3-epoxide cyclase as a model for the development of new drugs.

Authors:  L Cattel; M Ceruti; F Viola; L Delprino; G Balliano; A Duriatti; P Bouvier-Navé
Journal:  Lipids       Date:  1986-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.